RANKL/Osteoprotegerin System and Bone Turnover in Hashimoto Thyroiditis

Area of Science:

• Endocrinology
• Bone Metabolism
• Autoimmunity

Background:

• Hypothyroidism is linked to bone metabolism alterations.
• The specific effects of hypothyroidism and autoimmunity in Hashimoto's thyroiditis (HT) on bone turnover mediators are not well understood.

Purpose of the Study:

• To investigate the impact of hypothyroidism and associated autoimmunity on bone turnover mediators in premenopausal women with Hashimoto's thyroiditis.
• To compare levels of osteoprotegerin (OPG), RANK ligand (RANKL), interleukin-6 (IL-6), osteocalcin (OC), C-telopeptide (CTX), and tartrate-resistant acid phosphatase 5b (TRAcP 5b) in hypothyroid HT patients, euthyroid HT patients, and healthy controls.

Main Methods:

• Cross-sectional study comparing three groups: hypothyroid premenopausal HT patients (n=30), euthyroid premenopausal HT patients (n=30), and healthy premenopausal controls (n=20).
• Measurement of serum levels of OPG, RANKL, IL-6, OC, CTX, and TRAcP 5b.
• Correlation analysis between thyroid-stimulating hormone (TSH) and measured bone turnover markers.

Main Results:

• Hypothyroid HT patients exhibited significantly lower levels of TRAcP 5b, CTX, OC, and IL-6 compared to euthyroid HT patients and controls.
• OPG levels were elevated, and RANKL levels were reduced in both hypothyroid and euthyroid HT patients compared to controls.
• TSH showed negative correlations with IL-6, OC, and TRAcP 5b, and a positive correlation with OPG. The RANKL/OPG ratio was independently associated with HT presence.

Conclusions:

• Hypothyroidism significantly slows bone turnover in premenopausal women with Hashimoto's thyroiditis.
• Thyroid autoimmunity may exert an independent influence on OPG and RANKL levels, distinct from the effects of hypothyroidism itself.